Advertisement
Screener

CVS HEALTH CORPORATION (CVS) Gain (Loss) on Extinguishment of Debt

2.3 / 5 stars · 55/120 Roast Me

CVS HEALTH CORPORATION Gain (Loss) on Extinguishment of Debt

CVS HEALTH CORPORATION (CVS) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-02-10

  • CVS HEALTH CORPORATION gain (loss) on extinguishment of debt for the quarter ending 2022-12-31 was $0.00.
  • CVS HEALTH CORPORATION gain (loss) on extinguishment of debt for the quarter ending 2022-09-30 was $0.00.
  • CVS HEALTH CORPORATION gain (loss) on extinguishment of debt for the quarter ending 2021-12-31 was -$89.00M.
  • CVS HEALTH CORPORATION gain (loss) on extinguishment of debt for the quarter ending 2021-09-30 was -$363.00M.
  • CVS HEALTH CORPORATION gain (loss) on extinguishment of debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • CVS HEALTH CORPORATION gain (loss) on extinguishment of debt for fiscal 2024 was $491.00M.
  • CVS HEALTH CORPORATION gain (loss) on extinguishment of debt for fiscal 2023 was $0.00.
  • CVS HEALTH CORPORATION gain (loss) on extinguishment of debt for fiscal 2022 was $0.00.
Period endGain (Loss) on Extinguishment of DebtGain (Loss) on Extinguishment of Debt 1 monthGain (Loss) on Extinguishment of Debt 3 monthGain (Loss) on Extinguishment of Debt 6 monthGain (Loss) on Extinguishment of Debt 9 monthGain (Loss) on Extinguishment of Debt 12 month
2025-12-31$0.00
10-K · filed 2026-02-10
2024-12-31$491.00M
10-K · filed 2026-02-10
2023-12-31$0.00
10-K · filed 2026-02-10
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12
$0.00
derived: sum of 2 quarters · filed 2025-02-12
$0.00
10-K · filed 2025-02-12
2022-09-30$0.00
10-Q · filed 2022-11-02
$0.00
10-Q · filed 2022-11-02
2021-12-31-$89.00M
10-K · filed 2024-02-07
-$89.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07
-$452.00M
derived: sum of 2 quarters · filed 2024-02-07
-$452.00M
10-K · filed 2024-02-07
2021-09-30-$363.00M
10-Q · filed 2022-11-02
-$363.00M
10-Q · filed 2022-11-02
2021-08-31-$363.00M
10-K · filed 2024-02-07
2020-12-31-$674.00M
8-K · filed 2023-05-25
-$674.00M
derived: 8-K 12 month − 10-Q 9 month · filed 2023-05-25
-$1.44B
derived: sum of 2 quarters · filed 2023-05-25
-$1.44B
8-K · filed 2023-05-25
2020-09-30-$766.00M
10-Q · filed 2021-11-03
-$766.00M
10-Q · filed 2021-11-03
2020-08-31-$766.00M
8-K · filed 2023-05-25
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09
-$79.00M
derived: sum of 2 quarters · filed 2022-02-09
-$79.00M
10-K · filed 2022-02-09
2019-09-30-$79.00M
10-Q · filed 2020-11-06
-$79.00M
10-Q · filed 2020-11-06
2019-08-31-$79.00M
10-K · filed 2022-02-09
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
$0.00
derived: sum of 2 quarters · filed 2021-02-16
$0.00
10-K · filed 2021-02-16
2018-09-30$0.00
10-Q · filed 2019-11-06
$0.00
10-Q · filed 2019-11-06
2017-12-31$0.00
10-K · filed 2020-02-18
2016-12-31$0.00
derived: 8-K 12 month − 10-Q 9 month · filed 2019-08-08
-$101.00M
derived: sum of 2 quarters · filed 2019-08-08
-$643.00M
derived: sum of 3 quarters · filed 2019-08-08
-$643.00M
8-K · filed 2019-08-08
2016-09-30-$101.00M
10-Q · filed 2017-11-06
-$643.00M
derived: sum of 2 quarters · filed 2017-11-06
-$643.00M
10-Q · filed 2017-11-06
2016-07-27-$101.00M
8-K · filed 2019-08-08
2016-06-30-$542.00M
10-Q · filed 2017-08-08
-$542.00M
10-Q · filed 2017-08-08
2016-05-31-$542.00M
8-K · filed 2019-08-08
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14
$0.00
derived: sum of 2 quarters · filed 2018-02-14
$0.00
derived: sum of 3 quarters · filed 2018-02-14
$0.00
10-K · filed 2018-02-14
2015-09-30$0.00
10-Q · filed 2016-11-08
$0.00
derived: sum of 2 quarters · filed 2016-11-08
$0.00
10-Q · filed 2016-11-08
2015-06-30$0.00
10-Q · filed 2016-08-02
$0.00
10-Q · filed 2016-08-02
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09
-$521.00M
derived: sum of 2 quarters · filed 2017-02-09
-$521.00M
10-K · filed 2017-02-09
2014-09-30-$521.00M
10-Q · filed 2015-10-30
-$521.00M
10-Q · filed 2015-10-30
2013-12-31$0.00
10-K · filed 2016-02-09
2012-12-31-$348.00M
10-K · filed 2015-02-10
2011-12-31$0.00
10-K · filed 2014-02-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
PETMED EXPRESS INC (PETS)United States$0.034B-1.41